PPD, Inc., a leading global contract research organisation, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1985, PPD has established itself as a pivotal player in the pharmaceutical and biotechnology sectors, providing comprehensive drug development and laboratory services. The company offers a range of core services, including clinical development, laboratory services, and patient and investigator recruitment, all designed to accelerate the delivery of new therapies to market. PPD's commitment to innovation and quality has earned it a strong market position, recognised for its expertise in managing complex clinical trials and its advanced technology solutions. With a focus on enhancing patient outcomes and streamlining the drug development process, PPD continues to achieve notable milestones, solidifying its reputation as a trusted partner in the life sciences industry.
How does PPD, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
PPD, Inc.'s score of 91 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
PPD, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Thermo Fisher Scientific Inc., which influences its climate commitments and initiatives. While PPD, Inc. has not disclosed its own emissions figures, it is important to note that its climate strategies and targets may be aligned with those of its parent company, Thermo Fisher Scientific Inc. This includes potential commitments to the Science Based Targets initiative (SBTi) and other sustainability frameworks, although specific reduction targets for PPD, Inc. have not been detailed. As a subsidiary, PPD, Inc. may inherit climate performance metrics and initiatives from Thermo Fisher Scientific Inc., which is actively engaged in reducing its carbon footprint. However, without specific emissions data or reduction targets from PPD, Inc. itself, the company's individual climate commitments remain unclear. In summary, while PPD, Inc. is part of a larger corporate family with potential climate initiatives, it currently lacks publicly available emissions data and specific reduction targets.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 |
PPD, Inc.'s Scope 3 emissions, which decreased by 26% last year and decreased by approximately 37% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 58% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PPD, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.